Strs Ohio Acquires Shares of 8,400 Celcuity, Inc. $CELC

Strs Ohio acquired a new stake in Celcuity, Inc. (NASDAQ:CELC) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 8,400 shares of the company’s stock, valued at approximately $415,000.

Several other institutional investors have also recently made changes to their positions in the business. Rhumbline Advisers boosted its holdings in Celcuity by 1.2% in the second quarter. Rhumbline Advisers now owns 42,697 shares of the company’s stock valued at $570,000 after purchasing an additional 503 shares during the last quarter. Intech Investment Management LLC raised its stake in shares of Celcuity by 5.2% during the 2nd quarter. Intech Investment Management LLC now owns 14,855 shares of the company’s stock valued at $198,000 after buying an additional 734 shares during the last quarter. BNP Paribas Financial Markets lifted its holdings in shares of Celcuity by 78.9% in the 2nd quarter. BNP Paribas Financial Markets now owns 2,647 shares of the company’s stock valued at $35,000 after buying an additional 1,167 shares during the period. Versant Capital Management Inc boosted its stake in shares of Celcuity by 611.2% in the third quarter. Versant Capital Management Inc now owns 1,593 shares of the company’s stock worth $79,000 after buying an additional 1,369 shares during the last quarter. Finally, Tema Etfs LLC boosted its stake in shares of Celcuity by 8.9% in the second quarter. Tema Etfs LLC now owns 17,011 shares of the company’s stock worth $227,000 after buying an additional 1,392 shares during the last quarter. Hedge funds and other institutional investors own 63.33% of the company’s stock.

Insider Activity at Celcuity

In related news, Director Richard E. Buller sold 3,000 shares of the stock in a transaction on Friday, December 5th. The stock was sold at an average price of $105.69, for a total value of $317,070.00. Following the completion of the transaction, the director directly owned 6,760 shares of the company’s stock, valued at approximately $714,464.40. This represents a 30.74% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director David Dalvey sold 20,000 shares of the firm’s stock in a transaction on Tuesday, January 27th. The shares were sold at an average price of $120.03, for a total value of $2,400,600.00. Following the completion of the transaction, the director owned 90,000 shares in the company, valued at $10,802,700. The trade was a 18.18% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 26,900 shares of company stock valued at $3,094,917 over the last quarter. 15.77% of the stock is owned by company insiders.

Analyst Ratings Changes

A number of brokerages have issued reports on CELC. Weiss Ratings reissued a “sell (d-)” rating on shares of Celcuity in a report on Wednesday, January 21st. HC Wainwright reaffirmed a “neutral” rating and set a $94.00 target price (up from $77.00) on shares of Celcuity in a report on Monday, November 17th. Jefferies Financial Group increased their price target on shares of Celcuity from $108.00 to $134.00 and gave the stock a “buy” rating in a report on Tuesday, December 2nd. Stifel Nicolaus raised their price target on shares of Celcuity from $68.00 to $115.00 and gave the company a “buy” rating in a research report on Thursday, November 13th. Finally, Wall Street Zen downgraded shares of Celcuity from a “hold” rating to a “sell” rating in a research report on Sunday, October 26th. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $105.25.

Celcuity Stock Down 2.4%

CELC opened at $109.42 on Friday. The company has a market cap of $5.06 billion, a PE ratio of -29.81 and a beta of 0.25. Celcuity, Inc. has a twelve month low of $7.57 and a twelve month high of $120.32. The company has a 50-day moving average price of $104.24 and a 200 day moving average price of $72.14. The company has a quick ratio of 12.26, a current ratio of 12.26 and a debt-to-equity ratio of 2.74.

Celcuity (NASDAQ:CELC) last posted its quarterly earnings data on Wednesday, November 12th. The company reported ($0.92) EPS for the quarter, topping the consensus estimate of ($1.05) by $0.13. Sell-side analysts expect that Celcuity, Inc. will post -2.62 earnings per share for the current fiscal year.

About Celcuity

Celcuity, Inc is a clinical-stage biotechnology company specializing in precision oncology diagnostics. The company develops and commercializes predictive biomarker assays designed to identify which patients are most likely to benefit from targeted cancer therapies. By integrating functional profiling of tumor cells with molecular analyses, Celcuity seeks to optimize treatment selection and improve outcomes for patients with solid tumors.

Celcuity’s proprietary platform evaluates tumor cell sensitivity to various therapeutic agents using ex vivo assays that measure DNA damage response and other critical pathways.